Mantle cell lymphoma (MCL) is a rare cancer affecting the lymphatic system. It shares characteristics with other types of lymphomas, but understanding the signs and symptoms of MCL can help a person ...

Panelists discuss how, coming into ASH 2024, the largest unmet needs in the treatment and management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) include improving outcomes for ...

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations. Today we are ...

BTK inhibitors (BTKi) in mantle cell lymphoma (MCL) are examined by Tycel J. Phillips, MD, particularly as potential first-line therapy.

People with mantle cell lymphoma (MCL) often need to try different treatments to control their cancer. MCL can be hard to treat because it is aggressive and usually not curable. Jaypirca offers a new ...

Research offers promising insights into the ideal frontline therapies for mantle cell lymphoma (MCL), but there are continued unmet needs in the relapsed/refractory setting, blood cancer specialists ...